Increased Sensitivity to Complement and a Decreased Red Blood Cell Life Span in Mice Mosaic for a Nonfunctional Piga Gene
Open Access
- 1 November 1999
- journal article
- Published by American Society of Hematology in Blood
- Vol. 94 (9) , 2945-2954
- https://doi.org/10.1182/blood.v94.9.2945
Abstract
The gene PIGA encodes one of the protein subunits of the 1-6-N acetylglucosaminyltransferase complex, which catalyses an early step in the biosynthesis of glycosyl phosphatidylinositol (GPI) anchors. PIGA is somatically mutated in blood cells from patients with paroxysmal nocturnal hemoglobinuria (PNH), leading to deficiency of GPI-linked proteins on the cell surface. To investigate in detail how inactivating mutations of the PIGA gene affect hematopoiesis, we generated a mouse line, in whichloxP-mediated excision of part of exon 2 occurs on the expression of Cre. After crossbreeding with EIIa-cre transgenic mice, recombination occurs early in embryonic life. Mice that are mosaics for the recombined Piga gene are viable and lack GPI-linked proteins on a proportion of circulating blood cells. This resembles the coexistence of normal cells and PNH cells in patients with an established PNH clone. PIGA(−) blood cells in mosaic mice have biologic features characteristic of those classically seen in patients with PNH, including an increased sensitivity toward complement mediated lysis and a decreased life span in circulation. However, during the 12-month follow-up, the PIGA(−) cell population did not increase, clearly showing that a Piga gene mutation is not sufficient to cause the human disease, PNH.Keywords
This publication has 42 references indexed in Scilit:
- Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion.Journal of Clinical Investigation, 1997
- In vivo Analysis of the Cytoplasmic Domain of mlgE AntibodiesInternational Archives of Allergy and Immunology, 1997
- Visualizing an Olfactory Sensory MapCell, 1996
- The dual pathogenesis of paroxysmal nocturnal hemoglobinuriaCurrent Opinion in Hematology, 1996
- Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.The Journal of Experimental Medicine, 1995
- The Specificity of Alternative Complement Pathway‐Mediated Lysis of Erythrocytes: A Survey of Complement and Target Cells from 25 SpeciesScandinavian Journal of Immunology, 1993
- Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.Journal of Clinical Investigation, 1989
- Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.The Journal of Experimental Medicine, 1986
- Paroxysmal Nocturnal Haemoglobinuria: Variation in Clinical Severity and Association with Bone-Marrow HypoplasiaBritish Journal of Haematology, 1961
- Chronic Hemolytic Anemia with Paroxysmal Nocturnal HemoglobinuriaNew England Journal of Medicine, 1937